What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of study are Breast cancer, Cancer, Internal medicine, Genetics and Oncology.
His work carried out in the field of Breast cancer brings together such families of science as Obstetrics, Cancer research, Gynecology and Risk factor.
His Obstetrics research incorporates elements of Relative risk and Absolute risk reduction.
His research investigates the connection between Cancer and topics such as Frameshift mutation that intersect with issues in Nonsense mutation.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
His study looks at the relationship between Oncology and topics such as Tamoxifen, which overlap with Chemotherapy.
His most cited work include:
- Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies (2742 citations)
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer (2099 citations)
- Gene-Expression Profiles in Hereditary Breast Cancer (1533 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Breast cancer, Cancer, Oncology and Gynecology.
His research investigates the connection between Internal medicine and topics such as Endocrinology that intersect with problems in Diet and cancer.
His research integrates issues of Cancer research, Family history and Obstetrics in his study of Breast cancer.
His research in Cancer intersects with topics in Relative risk, Incidence and Disease.
In his study, Proportional hazards model is inextricably linked to Hazard ratio, which falls within the broad field of Oncology.
His Risk factor research includes elements of Surgery and Epidemiology.
He most often published in these fields:
- Internal medicine (44.19%)
- Breast cancer (43.88%)
- Cancer (29.30%)
What were the highlights of his more recent work (between 2017-2021)?
- Breast cancer (43.88%)
- Internal medicine (44.19%)
- Oncology (27.75%)
In recent papers he was focusing on the following fields of study:
Håkan Olsson mainly focuses on Breast cancer, Internal medicine, Oncology, Melanoma and Cancer research.
His biological study spans a wide range of topics, including Genome-wide association study, Hazard ratio, Confidence interval, Proportional hazards model and Prospective cohort study.
His Internal medicine study integrates concerns from other disciplines, such as Germline mutation and Genetic correlation.
His work in Oncology covers topics such as Loratadine which are related to areas like Lymphoma, Cancer therapy and Pancreatic cancer.
Håkan Olsson focuses mostly in the field of Cancer research, narrowing it down to matters related to Proteomics and, in some cases, Tumor progression.
He works mostly in the field of Cancer, limiting it down to topics relating to Disease and, in certain cases, Bioinformatics, as a part of the same area of interest.
Between 2017 and 2021, his most popular works were:
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma. (262 citations)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (83 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Melanoma, Internal medicine, Breast cancer, Oncology and Genome-wide association study.
The concepts of his Melanoma study are interwoven with issues in Tumor progression, Proteomics and Immunotherapy.
The study incorporates disciplines such as Trametinib and Allergy in addition to Internal medicine.
His Breast cancer research integrates issues from Gene mutation, Proportional hazards model, Hazard ratio, Prospective cohort study and Prostate cancer.
His work deals with themes such as Cancer, CDKN2A, Germline mutation, Chemotherapy and Desloratadine, which intersect with Oncology.
His Cancer study which covers DNA methylation that intersects with Case-control study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
